Replies to post #3624 on Revance Therapeutics Inc (RVNC)

[RVNCfan]

I think daxxify frontalis spot already lost none or mild grade, which is frustrating.
I hope to see the results with higher doses on frontalis

[dewophile]

Yes, but even in later time points if there appear to be minimal differences I don't know how to weigh these results, although I am not discounting the potential ramifications of this type of "study" on marketing. I would hope RVNC can counter detail this sort of thing (if in fact this is a pro Abbvie type of gimmick - which I really don't know, and perhaps is not at all but still looking at 5-10 patients like this I mean c'mon..